Shanta M. Messerli

1.4k total citations
31 papers, 1.1k citations indexed

About

Shanta M. Messerli is a scholar working on Molecular Biology, Oncology and Neurology. According to data from OpenAlex, Shanta M. Messerli has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Neurology. Recurrent topics in Shanta M. Messerli's work include Neurofibromatosis and Schwannoma Cases (5 papers), Virus-based gene therapy research (4 papers) and Epigenetics and DNA Methylation (4 papers). Shanta M. Messerli is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (5 papers), Virus-based gene therapy research (4 papers) and Epigenetics and DNA Methylation (4 papers). Shanta M. Messerli collaborates with scholars based in United States, Germany and Italy. Shanta M. Messerli's co-authors include Ralph Weissleder, Xandra O. Breakefield, Khalid Shah, Hiroshi Maruta, Robert M. Greenberg, Evan Snyder, Yi Tang, Ravi S. Kasinathan, Shilpa Prabhakar and Victor Mautner and has published in prestigious journals such as PLoS ONE, Nature Cell Biology and Journal of Molecular Biology.

In The Last Decade

Shanta M. Messerli

31 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shanta M. Messerli United States 16 537 159 112 106 105 31 1.1k
LeeAnn Higgins United States 23 773 1.4× 156 1.0× 165 1.5× 35 0.3× 58 0.6× 39 1.4k
Stephen C. Pak United States 25 846 1.6× 202 1.3× 228 2.0× 69 0.7× 135 1.3× 53 1.9k
He‐Hsuan Hsiao Germany 24 1.3k 2.3× 130 0.8× 121 1.1× 30 0.3× 128 1.2× 39 1.8k
Paul A. Colussi United States 20 1.5k 2.7× 114 0.7× 261 2.3× 69 0.7× 91 0.9× 28 1.8k
Ayesha Murshid United States 26 1.5k 2.8× 142 0.9× 166 1.5× 48 0.5× 98 0.9× 43 2.1k
Anil K. Madugundu India 21 729 1.4× 85 0.5× 131 1.2× 15 0.1× 55 0.5× 58 1.3k
Manuel M. Sánchez del Pino Spain 24 967 1.8× 245 1.5× 136 1.2× 37 0.3× 50 0.5× 55 1.7k
Marco Siderius Netherlands 25 1.3k 2.4× 295 1.9× 447 4.0× 38 0.4× 64 0.6× 69 2.1k
Li W China 17 531 1.0× 84 0.5× 62 0.6× 55 0.5× 69 0.7× 107 1.2k
Farzin Gharahdaghi United States 8 815 1.5× 93 0.6× 63 0.6× 34 0.3× 70 0.7× 8 1.3k

Countries citing papers authored by Shanta M. Messerli

Since Specialization
Citations

This map shows the geographic impact of Shanta M. Messerli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shanta M. Messerli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shanta M. Messerli more than expected).

Fields of papers citing papers by Shanta M. Messerli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shanta M. Messerli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shanta M. Messerli. The network helps show where Shanta M. Messerli may publish in the future.

Co-authorship network of co-authors of Shanta M. Messerli

This figure shows the co-authorship network connecting the top 25 collaborators of Shanta M. Messerli. A scholar is included among the top collaborators of Shanta M. Messerli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shanta M. Messerli. Shanta M. Messerli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhuang, Yongxian, et al.. (2023). Ability of metformin to deplete NAD+ contributes to cancer cell susceptibility to metformin cytotoxicity and is dependent on NAMPT expression. Frontiers in Oncology. 13. 1225220–1225220. 2 indexed citations
3.
Messerli, Shanta M., et al.. (2023). Applied Electric Fields Polarize Initiation and Growth of Endothelial Sprouts. Journal of Tissue Engineering and Regenerative Medicine. 2023. 1–12. 1 indexed citations
4.
Puente, Pilar de la, et al.. (2022). Reduction of Metastasis via Epigenetic Modulation in a Murine Model of Metastatic Triple Negative Breast Cancer (TNBC). Cancers. 14(7). 1753–1753. 12 indexed citations
5.
Sani, Rajesh K., et al.. (2022). BASIN: A Semi-automatic Workflow, with Machine Learning Segmentation, for Objective Statistical Analysis of Biomedical and Biofilm Image Datasets. Journal of Molecular Biology. 435(2). 167895–167895. 5 indexed citations
6.
7.
Messerli, Shanta M., et al.. (2020). Lactate induces PD-L1 in HRASG12V-positive oropharyngeal squamous cell carcinoma. Oncotarget. 11(17). 1493–1504. 4 indexed citations
8.
Hsia, Carleton J. C., Shanta M. Messerli, & W. Keith Miskimins. (2019). Can Anti-Metastatic Albumin-based Superoxide Dismutase Mimetic Serve as a “Moonshot” Drug for Treatment for Brain Tumors - From Medulloblastoma to Glioblastoma?. Cell Biochemistry and Biophysics. 77(2). 121–122. 1 indexed citations
9.
Messerli, Shanta M., Amanda M. Schaefer, Yongxian Zhuang, et al.. (2019). Use of Antimetastatic SOD3-Mimetic Albumin as a Primer in Triple Negative Breast Cancer. Journal of Oncology. 2019. 1–11. 9 indexed citations
10.
Messerli, Shanta M., et al.. (2017). Therapeutic Targeting of PTK7 is Cytotoxic in Atypical Teratoid Rhabdoid Tumors. Molecular Cancer Research. 15(8). 973–983. 18 indexed citations
11.
Messerli, Shanta M., et al.. (2017). 4SC-202 as a Potential Treatment for the Pediatric Brain Tumor Medulloblastoma. Brain Sciences. 7(11). 147–147. 18 indexed citations
12.
Chowanadisai, Winyoo, Shanta M. Messerli, Daniel Miller, et al.. (2016). Cisplatin Resistant Spheroids Model Clinically Relevant Survival Mechanisms in Ovarian Tumors. PLoS ONE. 11(3). e0151089–e0151089. 43 indexed citations
13.
Alavian, Kambiz N., Hongmei Li, Leon P. Collis, et al.. (2011). Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthase. Nature Cell Biology. 13(10). 1224–1233. 221 indexed citations
14.
Messerli, Shanta M., Ravi S. Kasinathan, William M. Morgan, Stefani Spranger, & Robert M. Greenberg. (2009). Schistosoma mansoni P-glycoprotein levels increase in response to praziquantel exposure and correlate with reduced praziquantel susceptibility. Molecular and Biochemical Parasitology. 167(1). 54–59. 61 indexed citations
15.
Messerli, Shanta M., Mok‐Ryeon Ahn, Kazuhiro Kunimasa, et al.. (2008). Artepillin C (ARC) in Brazilian green propolis selectively blocks oncogenic PAK1 signaling and suppresses the growth of NF tumors in mice. Phytotherapy Research. 23(3). 423–427. 82 indexed citations
16.
Demestre, Maria, Shanta M. Messerli, Nicola Celli, et al.. (2008). CAPE (caffeic acid phenethyl ester)‐based propolis extract (Bio 30) suppresses the growth of human neurofibromatosis (NF) tumor xenografts in mice. Phytotherapy Research. 23(2). 226–230. 76 indexed citations
17.
Prabhakar, Shilpa, Shanta M. Messerli, Anat Stemmer‐Rachamimov, et al.. (2007). Treatment of Implantable NF2 Schwannoma Tumor Models with Oncolytic Herpes Simplex Virus G47Δ. Cancer Gene Therapy. 14(5). 460–467. 35 indexed citations
18.
Messerli, Shanta M., Shilpa Prabhakar, Yi Tang, et al.. (2006). Treatment of Schwannomas with an Oncolytic Recombinant Herpes Simplex Virus in Murine Models of Neurofibromatosis Type 2. Human Gene Therapy. 17(1). 20–30. 33 indexed citations
19.
Messerli, Shanta M., Shilpa Prabhakar, Yi Tang, et al.. (2004). A Novel Method for Imaging Apoptosis Using a Caspase-1 Near-Infrared Fluorescent Probe. Neoplasia. 6(2). 95–105. 77 indexed citations
20.
Messerli, Shanta M., Y Tang, Marco Giovannini, et al.. (2002). Detection of Spontaneous Schwannomas by MRI in a Transgenic Murine Model of Neurofibromatosis Type 2. Neoplasia. 4(6). 501–509. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by LeeAnn Higgins Breakdown of academic impact, for papers by Stephen C. Pak Breakdown of academic impact, for papers by He‐Hsuan Hsiao Breakdown of academic impact, for papers by Paul A. Colussi Breakdown of academic impact, for papers by Ayesha Murshid Breakdown of academic impact, for papers by Anil K. Madugundu Breakdown of academic impact, for papers by Manuel M. Sánchez del Pino Breakdown of academic impact, for papers by Marco Siderius Breakdown of academic impact, for papers by Li W Breakdown of academic impact, for papers by Farzin Gharahdaghi
Rankless by CCL
2026